BLOG

Fierce-Biotech

Arrowhead can see the Horizon with $700M biobucks pact for an early RNA gout med

Arrowhead Pharmaceuticals has added to its collection of RNA collaborations with a $40 million upfront deal with Horizon Therapeutics.